Company intelligence / Profile preview

Citra Labs

Braintree, Massachusetts, United Statescitralab.lk ↗

Ownership: Private
Employees: ~49
Development stage: Commercial

Overview

Citra Labs develops and markets commercialized citrate-based anticoagulant solutions and blood rejuvenation products used in clinical settings for the restoration of stored red blood cells and autologous platelet-rich plasma production. These products are FDA-regulated, with a history of regulatory inspections.[1][3][5][6]

Therapeutic areas: Hematology
Modalities: Small molecule (citrate-based anticoagulants)Biologic (blood rejuvenation solutions)
Industry: Biotech

Drug pipeline

1 asset

PIPA solution

Preclinical

Partnerships

Zimmer Biomet Holdings Inc [parent company relationship]

Beyond the preview

Go deeper on Citra Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citra Labs.

Explore the full profile